Nardin, C., Mateus, C., Texier, M., Lanoy, E., Hibat-Allah, S., Ammari, S., . . . Dhermain, F. (2017). CMET-21. TOLERANCE AND OUTCOMES OF STEREOTACTIC RADIOSURGERY COMBINED WITH ANTI-PD1 (PEMBROLIZUMAB) FOR MELANOMA BRAIN METASTASES. Neuro Oncol.
Citação norma ChicagoNardin, Charlée, Christine Mateus, Matthieu Texier, Emilie Lanoy, Salima Hibat-Allah, Sami Ammari, Caroline Robert, and Frederic Dhermain. "CMET-21. TOLERANCE AND OUTCOMES OF STEREOTACTIC RADIOSURGERY COMBINED WITH ANTI-PD1 (PEMBROLIZUMAB) FOR MELANOMA BRAIN METASTASES." Neuro Oncol 2017.
Citação norma MLANardin, Charlée, et al. "CMET-21. TOLERANCE AND OUTCOMES OF STEREOTACTIC RADIOSURGERY COMBINED WITH ANTI-PD1 (PEMBROLIZUMAB) FOR MELANOMA BRAIN METASTASES." Neuro Oncol 2017.